ATROVENT UDV 20/0.25 MG 2 ML

ATROVENT UDVs are indicated for treatment of reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD).

DIRECTION TO USE

AS PRESCRIBED BY THE DOCTOR

SIDE EFFECTS

Bronchitis · Worsening of COPD · Shortness of breath · Headache · Dry mouth · Nausea